Actionable Druggable Genome-Wide Mendelian Randomization Identifies Repurposing Opportunities for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Actionable Druggable Genome-Wide Mendelian Randomization Identifies Repurposing Opportunities for COVID-19
Nat. Med. 2021 Apr 01;27(4)668-676, L Gaziano, C Giambartolomei, AC Pereira, A Gaulton, DC Posner, SA Swanson, YL Ho, SK Iyengar, NM Kosik, M Vujkovic, DR Gagnon, AP Bento, I Barrio-Hernandez, L Rönnblom, N Hagberg, C Lundtoft, C Langenberg, M Pietzner, D Valentine, S Gustincich, GG Tartaglia, E Allara, P Surendran, S Burgess, JH Zhao, JE Peters, BP Prins, ED Angelantonio, P Devineni, Y Shi, KE Lynch, SL DuVall, H Garcon, LO Thomann, JJ Zhou, BR Gorman, JE Huffman, CJ O'Donnell, PS Tsao, JC Beckham, S Pyarajan, S Muralidhar, GD Huang, R Ramoni, P Beltrao, J Danesh, AM Hung, KM Chang, YV Sun, J Joseph, AR Leach, TL Edwards, K Cho, JM Gaziano, AS Butterworth, JP CasasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.